Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Inmed Pharmaceuticals Inc (INM)

Inmed Pharmaceuticals Inc (INM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Mentari Therapeutics Announces $200 Million Private Placement for Migraine Prevention Pipeline PR Newswire - Wed Jul 22, 6:00AM CDT

WALTHAM, Mass. , July 22, 2026 /PRNewswire/ -- Mentari Therapeutics, Inc. ("Mentari"), a privately-held biotechnology company developing therapies for migraine prevention, today announced a $200...

INM : 2.1400 (+38.96%)
Are ESI, INM, HUN, OLN Obtaining Fair Deals for their Shareholders? PR Newswire - Mon Jul 6, 6:15PM CDT

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

HUN : 12.90 (+2.30%)
OLN : 23.70 (+2.38%)
INM : 2.1400 (+38.96%)
ESI : 39.12 (+2.33%)
InMed Pharmaceuticals and Mentari Therapeutics Announce Amendment to Merger Agreement and Filing of Registration Statement on Form S-4 Newsfile - Mon Jul 6, 5:20PM CDT

Vancouver, British Columbia and San Francisco, California--(Newsfile Corp. - July 6, 2026) - InMed Pharmaceuticals, Inc. (NASDAQ: INM) ("InMed" or the "Company") today announced that it has entered into...

INM : 2.1400 (+38.96%)
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--NIMU, INM, OLN, and HUN PR Newswire - Mon Jul 6, 1:18PM CDT

NEW YORK , July 6, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde  with Monteverde & Associates PC  (the "M&A Class Action Firm"), has recovered millions of dollars for...

HUN : 12.90 (+2.30%)
OLN : 23.70 (+2.38%)
NIMU : 0.0900 (+20.00%)
INM : 2.1400 (+38.96%)
Are GBTG, INM, CZR, TMHC Obtaining Fair Deals for their Shareholders? PR Newswire - Fri Jun 12, 10:51AM CDT

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

TMHC : 72.47 (-0.01%)
INM : 2.1400 (+38.96%)
CZR : 30.03 (-0.12%)
GBTG : 9.41 (unch)
InMed Pharmaceuticals Regains Compliance with Nasdaq Continued Listing Requirements Newsfile - Thu Jun 4, 4:08PM CDT

Vancouver, British Columbia--(Newsfile Corp. - June 4, 2026) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), today announce that it had received written notice from the Listing...

INM : 2.1400 (+38.96%)
Are RAMP, INM, D, NEE Obtaining Fair Deals for their Shareholders? PR Newswire - Thu May 28, 5:57PM CDT

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

D : 70.42 (+0.82%)
RAMP : 37.83 (-0.24%)
INM : 2.1400 (+38.96%)
NEE : 88.75 (+0.93%)
SHAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--RAMP, NEE, D, and INM PR Newswire - Thu May 28, 1:40PM CDT

NEW YORK , May 28, 2026 /PRNewswire/ -- Class Action Attorney  Juan Monteverde  with Monteverde & Associates PC  (the "M&A Class Action Firm"), has recovered millions of dollars for...

D : 70.42 (+0.82%)
RAMP : 37.83 (-0.24%)
INM : 2.1400 (+38.96%)
NEE : 88.75 (+0.93%)
Beauty pharmaceutical research by Chokniti-Studio via Shutterstock
INM Stock Alert: What to Know as InMed, Mentari Announce Merger Barchart - Wed May 20, 12:01PM CDT

InMed stock rallied yesterday on a merger announcement with Mentari Therapeutics. Here’s why the transaction is concerning for INM investors.

INM : 2.1400 (+38.96%)
INM Stock Alert: Halper Sadeh LLC is Investigating Whether InMed Pharmaceuticals, Inc. is Obtaining a Fair Price for its Shareholders Business Wire - Tue May 19, 9:56AM CDT

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transaction may contain terms that could limit superior...

INM : 2.1400 (+38.96%)

Barchart Exclusives

Super Micro Stock Pops on Upbeat Q4 Forecast. 2 Reasons to Stay Bullish. Barchart - 3 minutes ago
Super Micro's stronger-than-expected fourth-quarter update strengthens the view that AI infrastructure demand remains robust and that the company is executing well. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.